The β-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets

Current Medicinal Chemistry

Volumn 18, Issue 9, 2011, Pages 1318-1324

  Singh, V ^a   Mani, I ^b,c   Chaudhary, D K ^c   Somvanshi, P ^d  

^a UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^b BANARAS HINDU UNIVERSITY   (India)

^c NATIONAL BUREAU OF FISH GENETIC RESOURCES   (India)

^d Bioinformatics Centre   (India)

Author keywords

Drugs; Infection; Mycobacterium tuberculosis; Vaccine; Virulence

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; 5 (4' BENZYLOXYBIPHENYL 4 METHYL) 4 HYDROXY 3,5 DIMETHYL 5H THIOPHEN 2 ONE; ETHIONAMIDE; FATTY ACID SYNTHASE; ISONIAZID; MYCOLIC ACID; NCI 172033; PYRAZINAMIDE; THIOLACTOMYCIN; THIOLACTOMYCIN DERIVATIVE; TIOCARLIDE; TRICLOSAN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GENOME; BACTERICIDAL ACTIVITY; BIOFILM; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG TARGETING; ENZYME STRUCTURE; FATTY ACID SYNTHESIS; HUMAN; IC 50; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN FUNCTION;

3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE; ANTITUBERCULAR AGENTS; FATTY ACIDS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PROTEIN STRUCTURE, TERTIARY; TUBERCULOSIS;

EID: 79952795109     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029636     Document Type: Article

References (50)

1. Dolin, P.J.; Raviglione, M.C.; Kochi, A. Global tuberculosis incidence and mortality during 1990-2000. Bull. World Health Organ., 1994, 72, 213-20.
2. Cole, S.T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S.V.; Eiglmeier, K.; Gas, S.; Barry, C.E.; III, Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, S.; Osborne, J.; Quail, M.A.; Rajandram, M.A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, S.; Squares, S.; Sqares, R.; Sulston, J.E.; Taylor, K.; Whitehead, S.; Barrel, B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393, 537-44. (Pubitemid 28319235)
3. Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev., 2003, 16(3), 463-96. (Pubitemid 36871317)
4. Somvanshi, P.; Singh, V.; Seth, P.K. In silico prediction of epitopes in virulence proteins of Mycobacterium tuberculosis H37Rv for diagnostic and subunit vaccine design. J. Proteom. Bioinform., 2008, 1, 143-53.
5. Shen, H.; Wang, F.; Zhang, Y.; Huang, Q.; Xu, S.; Hu, H.; Yue, J.; Wang, H. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis. FEBS J., 2009, 276(1), 144-54.
6. Lin, X.; Xu, S.; Yang, Y.; Wu, J.; Wang, H.; Shen, H.; Wang, H. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv. Protein Expr. Purif., 2009, 64(1), 8-15.
7. + dependent DNA ligase from Mycobacterium tuberculosis. Protein Peptide Lett., 2010, 17(2), 269-76.
8. Khedkar, S.A.; Malde, A.K.; Coutinho, E.C. Comparative protein modeling of methionine S-adenosyltransferase (MAT) enzyme from Mycobacterium tuberculosis: A potential target for antituberculosis drug discovery. J. Mol. Graph. Model., 2005, 23, 355-66. (Pubitemid 40164749)
9. Singh, V.; Somvanshi, P. Targeting the peptide deformylase of Mycobacterium tuberculosis leads to drug discovery. Lett. Drug Des. Discov., 2009, 6(7), 487-493.
10. Chopra, P.; Meena, L.S.; Singh, Y. New drug targets for Mycobacterium tuberculosis. Indian J. Med. Res., 2003, 117, 1-9. (Pubitemid 36826748)
11. Glickman, M.S.; Cox, J.S.; Jacobs, W.R., Jr A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell, 2000, 5, 717-27.
12. Dao, D.N.; Sweeney, K.; Hsu, T.; Gurcha, S.S.; Nascimento, I.P.; Roshevsky, D. Besra, G.S.; Chan, J.; Porcelli, S.A.;. Jacobs, W.R.; Jr. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL- 12 production. PLoS Pathog., 2008, 4, e1000081.
13. Barry, C.E. III. Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosis. Trends Microbiol., 2001, 9, 237-41. (Pubitemid 32402233)
14. Barry, C.E.; Lee, R.E.; Mdluli, K.; Sampson, A.E.; Schroeder, B.G.; Slayden, R.A.; Yuan, Y. Mycolic acids: Structure, biosynthesis and physiological functions. Prog. Lipid Res., 1998, 37, 143-179. (Pubitemid 28391410)
15. Bloch, K. Fatty acid synthases from Mycobacterium phlei. Methods Enzymol., 1975, 35, 84-90.
16. Qureshi, N.; Sathyamoorthy, N.; Takayama, K. Biosynthesis of C30 to C56 fatty acids by an extract of Mycobacterium tuberculosis H37Ra. J. Bacteriol., 1984, 157, 46-52. (Pubitemid 14223495)
17. Choi, K.H.; Kremer, L.; Besra, G.S.; Rock, C.O. Identification and substrate specificity of beta-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem., 2000, 275(36), 28201-7.
18. Scarsdale, J.N.; Kazanina, G.; He, X.; Reynolds, K.A.; Wright, H.T. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III. J. Biol. Chem., 2001, 276(23), 20516-22.
19. Kremer, L.; Nampoothiri, K.M.; Lesjean, S.; Dover, L.G.; Graham, S.; Betts, J.; Brennan, P.J.; Minnikin, D.E.; Locht, C.; Besra, G.S. Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA: AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J. Biol. Chem., 2001, 276, 27967-74.
20. Kremer, L.; Douglas, J.D.; Baulard, A.R.; Morehouse, C.; Guy, M.R.; Alland, D.; Dover, L. G.; Lakey, J.H.; Jacobs, W.R.; Jr., Brennan, P.J.; Minnikin, D. E.; Besra, G.S. Thiolactomycin and related analogues as novel antimycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J. Biol. Chem., 2000, 275, 16857-64. (Pubitemid 30398921)
21. Huang, Y.; Ge, J.; Yao, Y.; Wang, Q.; Shen, H.; Wang, H. Characterization and site-directed mutagenesis of the putative novel acyl carrier protein Rv0033 and Rv1344 from Mycobacterium tuberculosis. Biochem. Biophys. Res. Commun., 2006, 342(2), 618-24. (Pubitemid 43289035)
22. Bhatt, A.; Molle, V.; Besra, G.S.; Jacobs, W.R.; Jr., Kremer, L. The Mycobacterium tuberculosis FAS-II condensing enzymes: Their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol., 2007, 64, 1442-54. (Pubitemid 46900736)
23. Takayama, K.; Wang, C.; Besra, G.S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev.; 2005, 18, 81-01. (Pubitemid 40170662)
24. Marrakchi, H.; Ducasse, S.; Labesse, G.; Montrozier, H.; Margeat, E.; Emorine, L.; Charpentier, X.; Daffé, M.; Quémard, A. MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long chain fatty acid elongation system FAS-II. Microbiol., 2002, 148, 951-60. (Pubitemid 34436772)
25. Quemard, A.; Sacchettini, J.C.; Dessen, A.; Vilcheze, C.; Bittman, R.; Jacobs, W.R.; Jr, Blanchard, J.S. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry, 1995, 34, 8235-41.
26. Bhatt, A.; Kremer, L.; Dai, A.Z.; Sacchettini, J.C.; Jacobs, W.R. Jr. Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J. Bacteriol., 2005, 187, 7596-06.
27. Kremer, L.; Dover, L.G.; Carrère, S.; Nampoothiri, K.M.; Lesjean, S.; Brown, A.K.; Brennan, P.J.; Minnikin, D.E.; Locht, C.; Besra, G.S. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. Biochem. J., 2002, 364, 423-30. (Pubitemid 34620802)
28. Schaeffer, M.L.; Agnihotri, G.; Volker, C.; Kallender, H.; Brennan, P.J.; Lonsdale, J.T. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB. J. Biol. Chem., 2001, 276(50), 47029-37.
29. Takayama, K.; Qureshi, N. Structure and synthesis of lipids. In The Mycobacteria: A Sourcebook. Kubica, G.P., and Wayne, L.G. (eds). New York, NY: Marcel Dekker., 1984, 315-44.
30. Trivedi, O.A.; Arora, P.; Sridharan, V.; Tickoo, R.; Mohanty, D. Gokhale, R.S. Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature, 2004, 428, 441-45. (Pubitemid 38419691)
31. Gokhale, R.S.; Saxena, P.; Chopra, T.; Mohanty, D. Versatile polyketide enzymatic machinery for the biosynthesis of complex mycobacterial lipids. Nat. Prod. Rep., 2007, 24, 267-77. (Pubitemid 46496566)
32. Gande, R.; Gibson, K.J.; Brown, A.K.; Krumbach, K.; Dover, L.G.; Sahm, H.; Shioyama, S.; Oikawa, T.; Besra, G.S.; Eggeling, L. Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cgpks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J. Biol. Chem., 2004, 279, 44847-57. (Pubitemid 39430897)
33. Portevin, D.; De Sousa-D'Auria, C.; Houssin, C.; Grimaldi, C.; Chami, M.; Daffe, M.; Guilhot, C. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc. Natl. Acad. Sci. USA, 2004, 101, 314-19. (Pubitemid 38084247)
34. Kurth, D.G.; Gago, G.M.; de la Iglesia, A.; Bazet, L.B.; Lin, T.W.; Morbidoni, H.R.; Tsai, S.C.; Gramajo, H. ACCase 6 is the essential acetyl- CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria. Microbiology, 2009 , 155, 2664-75.
35. Qiu, X.; Janson, C.A.; Konstantinidis, A.K.; Nwagwu, S.; Silverman, C.; Smith, W.W.; Khandekar, S.; Lonsdale, J.; Abdel-Meguid, S.S. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. J. Biol. Chem., 1999, 274(51), 36465-71.
36. Nie, Z.; Perretta, C.; Lu, J.; Su, Y.; Margosiak, S.; Gajiwala, K.S.; Cortez, J.; Nikulin, V.; Yager, K.M.; Appelt, K.; Chu, S. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. J. Med. Chem., 2005, 48(5), 1596-09.
37. Léger, M.; Gavalda, S.; Guillet, V.; van der Rest, B.; Slama, N.; Montrozier, H.; Mourey, L.; Quémard, A.; Daffé, M.; Marrakchi, H. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis. Chem. Biol., 2009, 16(5), 510-9.
38. Brown, A.K.; Sridharan, S.; Kremer, L.; Lindenberg, S.; Dover, L.G.; Sacchettini, J.C.; Besra, G.S. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: Factors influencing catalysis and substrate specificity. J. Biol. Chem., 2005, 280(37), 32539-47. (Pubitemid 41361868)
39. Musayev, F.; Sachdeva, S.; Scarsdale, J.N.; Reynolds, K.A.; Wright, H.T. Crystal structure of a substrate complex of Mycobacterium tuberculosis betaketoacyl- Acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A. J Mol. Biol., 2005, 346(5), 1313-21. (Pubitemid 40248831)
40. Senior, S.J.; Illarionov, P.A.; Gurcha, S.S.; Campbell, I.B.; Schaeffer, M.L.; Minnikin, D.E.; Besra, G.S. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. Bioorg. Med. Chem. Lett., 2003, 13(21), 3685-8. (Pubitemid 37206487)
41. Luckner, S.R.; Machutta, C.A.; Tonge, P.J.; Kisker, C. Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin. Structure., 2009, 17(7), 1004-13.
42. Veyron-Churlet, R.; Bigot, S.; Guerrini, O.; Verdoux, S.; Malaga, W.; Daffé, M.; Zerbib, D. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions. J. Mol. Biol., 2005, 353(4), 847-58. (Pubitemid 41457386)
43. Ojha, A.; Anand, M.; Bhatt, A.; Kremer, L.; Jacobs, W.R.; Jr, Hatfull, G.F. GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell., 2005, 123, 861-873. (Pubitemid 41721032)
44. Sridharan, S.; Wang, L.; Brown, A.K.; Dover, L.G.; Kremer, L.; Besra, G.S.; Sacchettini, J.C. X-ray crystal structure of Mycobacterium tuberculosis betaketoacyl acyl carrier protein synthase II (mtKasB). J. Mol. Biol., 2007, 366, 469-80. (Pubitemid 46138102)
45. rd. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science, 1998, 280(5369), 1607-10. (Pubitemid 28277706)
46. Schroeder, E.K.; de Souza, N.; Santos, D.S.; Blanchard, J.S.; Basso, L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol., 2002, 3(3), 197-25.
47. Machutta, C.A.; Bommineni, G.R.; Luckner, S.R.; Kapilashrami, K.; Ruzsicska, B.; Simmerling, C.; Kisker, C.; Tonge, P.J. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin. J. Biol. Chem., 2010, 285(9), 6161-9.
48. Slayden, R.A.; Lee, R.E.; Armour, J.W.; Cooper, A.M.; Orme, I.M.; Brennan, P.J.; Besra, G.S. Antimycobacterial action of thiolactomycin: An inhibitor of fatty acid and mycolic acid synthesis. Antimicrob. Agents Chemother., 1996, 40(12), 2813-9. (Pubitemid 26404350)
49. Singh, V.; Somvanshi, P. Homology modeling of 3-oxoacyl-acyl carrier protein synthase II from Mycobacterium tuberculosis H37Rv and molecular docking for exploration of drugs. J. Mol. Model., 2009, 15(5), 453-60.
50. Gao, L.Y.; Laval, F.; Lawson, E.H.; Groger, R.K.; Woodruff, A.; Morisaki, J.H., Cox, J.S.; Daffe, M.; Brown, E.J. Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: Implications for therapy. Mol. Microbiol., 2003, 49, 1547-63. (Pubitemid 37153515)